Compare NEO & ATS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NEO | ATS |
|---|---|---|
| Founded | 2001 | 1978 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Precision Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.9B |
| IPO Year | 2008 | 2007 |
| Metric | NEO | ATS |
|---|---|---|
| Price | $19.19 | $18.68 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 1 |
| Target Price | $13.38 | ★ $35.00 |
| AVG Volume (30 Days) | ★ 1.7M | 252.1K |
| Earning Date | 04-28-2026 | 05-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $10.63 | $17.99 |
| Revenue Next Year | $9.73 | $4.52 |
| P/E Ratio | ★ N/A | $222.92 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.07 | $18.41 |
| 52 Week High | $20.05 | $35.82 |
| Indicator | NEO | ATS |
|---|---|---|
| Relative Strength Index (RSI) | 59.64 | 37.03 |
| Support Level | $16.87 | $18.53 |
| Resistance Level | $19.90 | $19.80 |
| Average True Range (ATR) | 0.80 | 0.45 |
| MACD | -0.03 | 0.16 |
| Stochastic Oscillator | 70.00 | 13.64 |
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
ATS Corp is engaged in planning, designing, building, commissioning and servicing automated manufacturing systems - including automation products and test solutions - for a broadly diversified base of customers. The company focuses in five key markets: life sciences, food & beverage, transportation, consumer products and energy. The Company's operations are reported as one operating segment, Automation Systems, which plans, allocates resources, builds capabilities and implements practices on a world-wide basis. The company has presence in Canada, United States, Germany, Italy, Other Europe, and Other.